Submitting clinical data in South Korea requires adherence to guidelines set by the Ministry of Food and Drug Safety (MFDS). Data must demonstrate safety, efficacy, and quality, and be collected according to Good Clinical Practice (GCP) standards. Submissions include trial protocols, patient data, statistical analysis, and compliance with ethical and regulatory requirements.
